Ravasio, Roberto, Lorenzo Antonuzzo, Marco Danova, and Paolo Pronzato. “A Budget Impact Analysis of Pegfilgrastim Biosimilar in the Treatment of Febrile Neutropenia in Italy: Analisi Di Budget Impact Del Biosimilare Di Pegfilgrastim Nel Trattamento Della Neutropenia Febbrile in Italia”. AboutOpen 7, no. 1 (March 2, 2020): 4–8. Accessed November 21, 2024. https://journals.aboutscience.eu/index.php/aboutopen/article/view/2030.